Search for: "KV Pharmaceutical Company" Results 21 - 40 of 67
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Feb 2009, 3:18 pm
According to an FDA press release, Ethex Corporation, a division of KV Pharmaceutical, recalled the painkiller Dec. 23 because the manufactured pills were larger than intended. [read post]
10 Mar 2011, 8:55 am
Manufactured by KV Pharmaceuticals, if you want the drug today it is $20 per injection.Next week it will be $1500.A drug for high-risk pregnant women has cost about $10 to $20 per injection. [read post]
12 Oct 2009, 12:38 pm
Citigroup Global Market, Inc. has filed a motion to dismiss an action against it by KV Pharmaceuticals Co. arising out of sales of auction rate securities, according to an August 25 article in Law360 by Christine Caufield entitled "Citigroup Argues KV Pharma Knew ARS Risks. [read post]
6 Sep 2012, 5:25 pm by FDABlog HPM
In early August, KV announced that the company filed for Chapter 11 bankruptcy protection. [read post]
10 Mar 2011, 7:58 am by Maxwell Kennerly
That's a big win for patients out there and a big loss for KV Pharmaceuticals, but it might not be the end of it. [read post]
4 Sep 2009, 12:11 pm
KV Pharmaceutical Company, C.A. 08-223-JJF (D. [read post]
29 Oct 2006, 7:43 pm
Harper KV Pharmaceutical Company recently filed a citizen petition asking the FDA to relist U.S. [read post]
6 May 2010, 7:10 am by Carey, Danis & Lowe
Last month, I wrote about the legal and financial troubles at Ethex Corp., whose parent company is KV Pharmaceuticals here in St. [read post]
31 Jul 2008, 9:44 pm
  According to the company's web site: KV Pharmaceutical, with headquarters in St. [read post]
25 Mar 2009, 12:17 pm
As we have reported previously, here, during the past year there have been other cGMP violations leading to generic drug recalls by Actavis, ETHEX / KV Pharmaceutical, and Sandoz / Novartis. [read post]
27 May 2010, 6:51 am by Carey, Danis & Lowe
Within the last two months, I've written about three other companies whose manufacturing practices have been under FDA's scrutiny, including McNeil Pharmaceuticals, Teva Pharmaceuticals and KV Pharmaceutical. [read post]
22 Sep 2011, 9:59 am
Oral argument argued before the Eighth Circuit U.S. [read post]
10 May 2011, 7:25 am by Lawrence B. Ebert
When KV announced it would charge about hundred times what patients were paying at compounding pharmacies, a firestorm of criticism ensued, and the pharmaceutical company has backpedaled on its pricing. [read post]
3 Apr 2011, 6:59 am by Frank Pasquale
As the FDA states on its website: FDA understands that the manufacturer of Makena, KV Pharmaceuticals, has sent letters to pharmacists indicating that FDA will no longer exercise enforcement discretion with regard to compounded versions of Makena. [read post]
9 Jul 2012, 2:00 am by Kara OBrien
We also discuss a First Circuit decision affirming the dismissal of a securities fraud action against Textron; a Second Circuit ruling addressing the standard for pleading a failure to disclose “known uncertainties” under Item 303 of Regulation S-K; and an Eighth Circuit decision reversing the dismissal of a securities fraud action against KV Pharmaceutical Company. [read post]
9 Jul 2012, 2:00 am by Kara OBrien
We also discuss a First Circuit decision affirming the dismissal of a securities fraud action against Textron; a Second Circuit ruling addressing the standard for pleading a failure to disclose “known uncertainties” under Item 303 of Regulation S-K; and an Eighth Circuit decision reversing the dismissal of a securities fraud action against KV Pharmaceutical Company. [read post]
2 Feb 2009, 9:51 am
This January 2008 press release from KV Pharmaceutical, the parent company of ETHEX, includes a list of the more than 60 generic drugs being recalled by ETHEX. [read post]